Nyxoah (NYXH) Price & Analysis

Compare

111 Followers

NYXH Stock Chart & Stats

Day’s Range― - ―

52-Week Range$5.55 - $11.87

Previous CloseN/A

Volume100.61K

Average Volume (3M)41.76K

Market Cap

$273.16M

Enterprise Value$202.32M

Total Cash (Recent Filing)N/A

Total Debt (Recent Filing)N/A

Price to Earnings (P/E)―

Beta0.94

Next Earnings

Aug 18, 2025

EPS Estimate

-0.66

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.70

Shares Outstanding37,429,264

10 Day Avg. Volume64,145

30 Day Avg. Volume41,760

Financial Highlights & Ratios

PEG RatioN/A

Price to Book (P/B)0.00

Price to Sales (P/S)0.00

P/FCF Ratio0.00

Enterprise Value/Market Cap0.74

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

$14.30

Price Target Upside90.67% Upside

Rating ConsensusStrong Buy

Number of Analyst Covering3

Bulls Say, Bears Say

Bulls Say

Clinical EfficacyGenio system resulted in a clinically meaningful 71.0% median reduction in Apnea Hypopnea Index (AHI) while sleeping supine at 12 months compared with baseline.

Market OpportunityThe target market for Genio in the U.S. is approximately 510,000 patients, representing an annual total addressable market of approximately $10 billion.

Regulatory ProgressThe FDA has issued an Approvable Letter for Nyxoah's Genio system, indicating a positive step towards full market approval.

Bears Say

Manufacturing IssuesThere is an issue with the FDA’s acceptance of data regarding manufacturing processes, delaying the anticipated approval.

Regulatory DelaysThe U.S. launch projection for Genio has been moved from early 3Q25 to early 1Q26 due to the pending completion of manufacturing validation.

Sales Performance4Q24 Genio sales were below estimates, with reported sales of €1.3M compared to an expected €2.4M.

Nyxoah News

Nyxoah receives FDA approval for Genio system

Nyxoah (NYXH) announced that the FDA has approved the Genio system for a subset of patients with moderate...

6h ago

NYXH

Nyxoah publishes DREAM study data in Journal of Clinical Sleep Medicine

Nyxoah (NYXH) announced that data from its DREAM pivotal study was published online in the Journal of Clinical...

11d ago

NYXH

Nyxoah’s DREAM Study Data Published, Highlighting Genio® System’s Efficacy

Nyxoah ( ($NYXH) ) has shared an announcement. On July 28, 2025, Nyxoah announced the publication of data...

11d ago

NYXH

Nyxoah’s Innovative Approach to Sleep Apnea: A Clinical Study Update

Nyxoah Sa (($NYXH)) announced an update on their ongoing clinical study. Nyxoah S.A. is conducting a multicenter study...

21d ago

NYXH

Nyxoah SA Announces New Share Issuance to Strengthen Financial Structure

An announcement from Nyxoah ( ($NYXH) ) is now available. On June 27, 2025, Nyxoah SA announced the...

1M ago

NYXH

Nyxoah Announces Change in Shareholder Voting Rights

An update from Nyxoah ( ($NYXH) ) is now available. On May 30, 2025, Nyxoah SA announced that...

2M ago

NYXH

Nyxoah SA Updates Share Capital and Voting Rights

Nyxoah ( ($NYXH) ) has shared an update. On May 23, 2025, Nyxoah SA announced the issuance of...

2M ago

NYXH

Nyxoah Sa’s Earnings Call: Progress Amid Challenges

Nyxoah Sa (($BE:NYXH)) has held its Q1 earnings call. Read on for the main highlights of the call....

3M ago

NYXH

Nyxoah Reports Q1 2025 Financial Results and FDA Progress

Nyxoah Sa ( ($NYXH) ) has released its Q1 earnings. Here is a breakdown of the information Nyxoah...

3M ago

NYXH

Nyxoah Nears FDA Approval for Genio® System Amid Q1 2025 Results

Nyxoah ( ($NYXH) ) has provided an announcement. On May 14, 2025, Nyxoah SA announced its financial and...

3M ago

NYXH

Nyxoah reports Q1 EPS (EUR 0.60) vs. (EUR 0.42) last year

Reports Q1 revenue EUR 1.06M vs. EUR 1.22M last year. “We are excited that we are in the...

3M ago

NYXH

Nyxoah Announces Changes in Shareholding by FMR LLC

Nyxoah ( ($NYXH) ) has provided an announcement. On May 9, 2025, Nyxoah SA announced that it received...

3M ago

NYXH

Nyxoah SA Schedules Shareholders’ Meetings for June 2025

The latest announcement is out from Nyxoah ( ($NYXH) ). Nyxoah SA announced on May 9, 2025, that...

3M ago

NYXH

Nyxoah price target lowered to $14 from $15 at Stifel

Stifel analyst Jonathan Block lowered the firm’s price target on Nyxoah (NYXH) to $14 from $15 and keeps...

4M ago

INSP

NYXH

NYXH FAQ

What was Nyxoah Sa’s price range in the past 12 months?

Nyxoah Sa lowest stock price was $5.55 and its highest was $11.87 in the past 12 months.

What is Nyxoah Sa’s market cap?

Nyxoah Sa’s market cap is $273.16M.

When is Nyxoah Sa’s upcoming earnings report date?

Nyxoah Sa’s upcoming earnings report date is Aug 18, 2025 which is in 9 days.

How were Nyxoah Sa’s earnings last quarter?

Nyxoah Sa released its earnings results on May 14, 2025. The company reported -$0.697 earnings per share for the quarter, missing the consensus estimate of -$0.553 by -$0.145.

Is Nyxoah Sa overvalued?

According to Wall Street analysts Nyxoah Sa’s price is currently Undervalued. Get more investment ideas with TipRanks Premium

Does Nyxoah Sa pay dividends?

Nyxoah Sa does not currently pay dividends.

What is Nyxoah Sa’s EPS estimate?

Nyxoah Sa’s EPS estimate is -0.66.

How many shares outstanding does Nyxoah Sa have?

Nyxoah Sa has 37,429,264 shares outstanding.

What happened to Nyxoah Sa’s price movement after its last earnings report?

Nyxoah Sa reported an EPS of -$0.697 in its last earnings report, missing expectations of -$0.553. Following the earnings report the stock price went up 4.844%.

Which hedge fund is a major shareholder of Nyxoah Sa?

Currently, no hedge funds are holding shares in NYXH

Nyxoah Stock Smart Score

Neutral

Fundamentals

Return on Equity

-76.77%

Trailing 12-Months

Asset Growth

20.27%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Nyxoah Sa

Nyxoah S.A., a medical technology company, focuses on the development and commercialization of solutions to treat sleep disordered breathing conditions. It offers Genio system, a CE-Marked, patient-centric, and hypoglossal neurostimulation therapy to treat moderate to severe obstructive sleep apnea. The company was incorporated in 2009 and is headquartered in Mont-Saint-Guibert, Belgium.

Nyxoah (NYXH) Earnings & Revenues

Historic Earnings Reports

NYXH Earnings Call

Q1 2025

0:00 / 0:00

Earnings Call Sentiment|Neutral

The earnings call presents a balanced outlook. While Nyxoah is making significant progress towards FDA approval and preparing for a U.S. launch with innovative strategies and market entry into the Middle East, it faces challenges with a slight revenue decline, increased operating loss, and a decreased cash position.View all NYXH earnings summaries

NYXH Stock 12 Month Forecast

Average Price Target

$14.30

▲(90.67% Upside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"5":"$5","8":"$8","11":"$11","14":"$14","17":"$17"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":16.9,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$16.90</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":14.3,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$14.30</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$12.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[5,8,11,14,17],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2024","6":"Nov<br/>2024","9":"Apr<br/>2025","12":"Jul<br/>2025","25":"Jul<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.55,8.269230769230768,8.988461538461538,9.707692307692307,10.426923076923076,11.146153846153846,11.865384615384613,12.584615384615383,13.303846153846152,14.023076923076921,14.74230769230769,15.46153846153846,16.18076923076923,{"y":16.9,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.55,8.069230769230769,8.588461538461539,9.107692307692307,9.626923076923077,10.146153846153846,10.665384615384616,11.184615384615384,11.703846153846154,12.223076923076924,12.742307692307692,13.26153846153846,13.78076923076923,{"y":14.3,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,7.55,7.892307692307692,8.234615384615385,8.576923076923077,8.919230769230769,9.26153846153846,9.603846153846153,9.946153846153846,10.288461538461538,10.63076923076923,10.973076923076924,11.315384615384616,11.657692307692308,{"y":12,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":9.48,"date":1714521600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.41,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.03,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.31,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.22,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.55,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.04,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.87,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":6.01,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.64,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.55,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >